Bi Asset Management Fondsmaeglerselskab A Bio Rad Laboratories, Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$304.11 - $351.99 $196,455 - $227,385	646 Added 82.93%	1,425 $493,000
Q4 2023 Feb 09, 2024	BUY	$269.37 - $365.04 $87,006 - $117,907	323 Added 70.83%	779 $252,000
Q2 2023 Aug 03, 2023	BUY	$359.49 - $486.4 $48,171 - $65,177	134 Added 41.61%	456 $173,000
Q1 2023 May 12, 2023	BUY	$418.69 - $503.0 $13,816 - $16,599	33 Added 11.42%	322 $154,000
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $27,081 - $35,112	77 Added 36.32%	289 $122,000
Q3 2022 Nov 07, 2022	SELL	$412.59 - $563.26 $55,699 - $76,040	-135 Reduced 38.9%	212 $88,000
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $160,893 - $207,214	347 New	347 $172,000

453

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.68B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.